Page last updated: 2024-08-26

diosgenin and palbociclib

diosgenin has been researched along with palbociclib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cai, E; Chen, R; Fu, H; Ke, K; Li, X; Shen, J; Shen, Z; Shi, X; Song, N; Wan, W; Wang, J; Xie, X; Zhang, Q; Zhang, R; Zhang, Z; Zuo, A	1

Other Studies

1 other study(ies) available for diosgenin and palbociclib

Article	Year
Polyphyllin I, a lethal partner of Palbociclib, suppresses non-small cell lung cancer through activation of p21/CDK2/Rb pathway Cell cycle (Georgetown, Tex.), 2021, Volume: 20, Issue:23 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Diosgenin; Humans; Lung Neoplasms; Piperazines; Pyridines; Retinoblastoma Protein; Signal Transduction	2021

Article

Year

Polyphyllin I, a lethal partner of Palbociclib, suppresses non-small cell lung cancer through activation of p21/CDK2/Rb pathway

Cell cycle (Georgetown, Tex.), 2021, Volume: 20, Issue:23

Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Diosgenin; Humans; Lung Neoplasms; Piperazines; Pyridines; Retinoblastoma Protein; Signal Transduction

2021